Cash FlowCash runway is expected to fund operations into the second half of 2027, providing financial stability for ongoing projects.
Financial PerformanceA $31 million lease litigation settlement removed a $58 million liability, ending Q2 with $141.4M in cash.
Technology DevelopmentRecent data demonstrated the effectiveness of ctLNPs in targeting T-cells, highlighting the potential of their technology in treating autoimmune diseases.